Identification of Serum Biomarkers and Therapeutic Targets for Aortic Diseases in Obesity (PRJCA025636)

Obesity is associated with an increased risk of aortic diseases and higher operative risks. Currently, there are no effective drugs available to prevent the occurrence and progression of aortic aneurysms or dissections. This study investigates potential biomarkers and therapeutic targets through multi-omics approaches.